Tiagabine is an anticonvulsant medication classified as a GABA reuptake inhibitor, indicated as an adjunctive therapy for the management of partial seizures in patients with epilepsy. This category provides… Read more

![Chemical structure of (R)-1-[4,4-Bis(3-methyl-2-thienyl)-3-oxybutyl]-3-piperidinecarboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F161014-55-7-R-1-44-Bis3-methyl-2-thienyl-3-oxybutyl-3-piperidinecarboxylic-Acid.png&w=3840&q=75)










![Chemical structure of Racemic Tiagabine Hydrochloride Mixture ((S)-(+),(R)-(-)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]n (1667235)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FRacemic-Tiagabine-Hydrochloride-Mixture-S-R-1-44-bis3-methyl-2-thienyl-3-butenyln-1667235.png&w=3840&q=75)

![Chemical structure of Tiagabine Related Compound A ((R)-ethyl 1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarbo (1667224)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FTiagabine-Related-Compound-A-R-ethyl-1-44-bis3-methyl-2-thienyl-3-butenyl-3-piperidinecarbo-1667224.png&w=3840&q=75)

Tiagabine is an anticonvulsant medication classified as a GABA reuptake inhibitor, indicated as an adjunctive therapy for the management of partial seizures in patients with epilepsy. This category provides a comprehensive collection of reference standards, including the active pharmaceutical ingredient, process-related impurities, synthetic intermediates, degradation products, and stable isotope labelled compounds. Pharmaceutical laboratories rely on these high-quality materials for accurate impurity profiling, method development, and rigorous quality control to ensure regulatory compliance and therapeutic safety. By utilizing these structurally characterized standards, analytical chemists can effectively identify potential contaminants and monitor stability throughout the manufacturing lifecycle. Stable isotope labelled versions of the drug serve as essential internal standards for precise quantification during mass spectrometry-based analytical procedures. Together, these reference materials support the stringent analytical requirements necessary for assessing the purity and stability of this therapeutic agent.